Ownership history in Candriam S.C.A. · 20 quarters on record
This page tracks every 13F SEC filing in which Candriam S.C.A. reported a position in AVIDITY BIOSCIENCES INC (RNA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 487,917 | +45,144 | +10.2% | 0.11% | $21.3M | — |
| 2025 Q2 | ADDED | 442,773 | +3,674 | +0.8% | 0.07% | $12.6M | — |
| 2025 Q1 | ADDED | 439,099 | +78,389 | +21.7% | 0.08% | $13.0M | — |
| 2024 Q4 | ADDED | 360,710 | +37,314 | +11.5% | 0.06% | $10.5M | — |
| 2024 Q3 | ADDED | 323,396 | +33,329 | +11.5% | 0.09% | $14.9M | — |
| 2023 Q4 | ADDED | 290,067 | +120,000 | +70.6% | 0.02% | $2.6M | — |
| 2023 Q3 | UNCHANGED | 170,067 | — | 0% | 0.01% | $1.1M | — |
| 2023 Q2 | UNCHANGED | 170,067 | — | 0% | 0.01% | $1.9M | — |
| 2023 Q1 | REDUCED | 170,067 | -41,000 | -19.4% | 0.02% | $2.4M | — |
| 2022 Q4 | UNCHANGED | 211,067 | — | 0% | 0.03% | $4.7M | — |
As of 2025 Q4 — sorted by position size